Stay updated on Nivolumab & Brentuximab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.

Latest updates to the Nivolumab & Brentuximab in Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdministrative updates show a new site revision (v3.4.2) and removal of the previous funding/operating-status notice; these changes do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding status notice and updated the page to revision 3.4.1, replacing revision 3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC labels, including a new 'Revision: v3.4.0'. Removed older QC label variants like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4 (v3.3.3 removed, v3.3.4 added).SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section shows additions and removals of trial sites across the US, Canada, and the UK (e.g., Alabama, Florida, British Columbia, Ontario, Oxfordshire, Surrey). These changes modify the list of active enrollment sites and where eligible participants can join the study.SummaryDifference2%

- Check92 days agoChange DetectedPublications section now notes that PubMed auto-fills the list and may not always pertain to the study, and includes a new Revision: v3.3.2. The older PubMed note and Revision: v3.2.0 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Brentuximab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.